Health and Me

Aarushi Bhadury

Common Nighttime Habit Could Lead You To Cardiovascular Health Issues: Study

People are often surprised by how even innocent habits can be the cause of their declining health. Many times, we take on these habits, maybe due to stress or due to work. However, it is important to understand the implications of it and how to counter its effects. A common habit that we all have is scrolling on our phones or watching the television before we go to sleep. Many people find it comforting to relax their minds like this. However, it may be doing more harm to your health than good. 

A new study suggests that a common habit, being exposed to light at night, might be increasing your chances of developing heart disease, heart failure, and stroke. Researchers found that people who had more light exposure from things like TVs, phones, and laptops during nighttime hours faced a higher risk of these serious heart-related problems. 

<h2>Tracking <span rel="noindex">Light Exposure and Heart Health</span> </h2>

The study looked at data from nearly 89,000 people in Britain. These participants wore special wrist sensors that measured how much light they were exposed to. Their health was then followed using their medical records for almost 10 years. The results showed that those who had the most light exposure at night had a significantly higher risk: 

<ul><li>23-32% higher risk of developing coronary artery disease (a common type of heart disease).</li><li>42-47% higher risk of having a heart attack.</li><li>28-32% more likely to suffer from an irregular heartbeat.</li><li>28-30% more likely to experience a stroke.</li></ul>

The researchers also noticed some specific trends. The links between more nighttime light exposure and heart failure or coronary artery disease were stronger for women. Meanwhile, the connections with heart failure and irregular heartbeat were more pronounced in younger people. 

The researchers concluded that "Night light exposure was a significant risk factor for developing cardiovascular diseases." They believe that "avoiding light at night may be a useful strategy for reducing risks of cardiovascular diseases," in addition to existing preventative measures.

It's well-known that light at night can disrupt your circadian rhythm, which is your body's natural internal clock controlling your sleep-wake cycle. Previous studies have shown that people whose body clocks are often disrupted, like shift workers, are more prone to heart problems. 

Interestingly, the research, which analyzed a massive 13 million hours of light exposure data, also found a positive side. People who were exposed to brighter light during the day had lower risks of coronary heart disease, heart failure, and stroke. 

<h2>New Factor in <span rel="noindex">Heart Health Prevention</span> </h2>

Experts behind the study stated that this was the first time night light had been identified as an important risk factor by looking at individuals' actual light exposure patterns and their <span>heart health</span>. They highlighted that heart diseases are a leading cause of illness and death worldwide. 

Current advice for preventing these diseases includes eating healthy, getting enough physical activity, and avoiding alcohol and tobacco. This study adds a new recommendation: avoiding night light could be a promising way to further prevent cardiovascular diseases. 

Health Conditions A-Z

health

Heart Health

Cardiovascular Health Issues

Light Exposure and Heart Health

Heart Health Prevention

light exposure patterns and heart health

using phone at night

Damar Hamlin Is Back For 2025 NFL Season, But His Cardiac Arrest Has Changed The Course Of The Game

'Jaws' Star Richard Dreyfuss Skips Fan Event After Being Diagnosed With Severe Bronchitis, Know What It Is

HIV Vaccine Research In South Africa Crumbles As U.S. Pulls Funding

Health & Wellness

Signs You Must Visit A Doctor For Your Back Pain

Avocado Meal Prep Ideas To Increase Healthy Fat In Your Diet

Arm Exercises You Can Do At Home

Quick-Office Lunches That Can Keep You Full-Longer

How Increased Screen Time Affects Children's Health

Homemade Recipe To Make Protein-Rich Pancakes With Healthy Alternatives

Push-Up Variations You Can Do At Home

Common Mistakes Running Mistakes People Make

Low-Calorie Foods That Keep You Full For Long

Yoga Poses That Help You Get Rid Of Back Pain

Natural Ways To Increase Protein In Your Diet

Managing Excessive Daytime Sleepiness – Tips To Try

How Much Protein Is Too Much?

High Fiber Indian Foods You Should Try

10 Easy Ways To Boost Daily Fiber Intake

Adding Walnut Oil To Your Diet? Benefits You Should Know

Drinks That Soothe Headaches And Migraines

Waist Exercises For More Toned Belly

This Is How Stress Affects Your Heart

Does Digital ‘Brain Rot’ Really Affect Your Health?

Dishes With Fermented Foods To Eat For Your Gut Health

Yoga Poses That Stimulate Good Bowel Health

Weekend Warrior Exercises For Full Body Movement

Weekend Meal Prep Ideas That Will Last You A Weekend

Easy Homemade Healthy Dishes For Long Afternoons

Silent Walking: Mental Health Booster That Keeps You Fit

Dumbbell Exercises You Can Do At Home

These Foods Are Keeping You Awake At Night

Ways to Manage Sugar Cravings

Your Body Doesn’t Want You To Lose Weight – Here's It Resists

High-Protein No Cook Dishes You Should Try

Yoga Poses That Aid In Digestion

Low Calorie Dinner Options For Weight Loss

Cardiac Arrest Vs. Heart Attack: Difference Explained Under 60 Seconds

High Protein Low-Carb Snacks To Have On The Go

Knee Exercises Desk Workers Should Do For Joint Health

Why Do I Feel Sleepy During The Day?

High Protein Early Morning Meals To Keep You Full Till Lunch

International Yoga Day 2025: Benefits of Doing Tadasana Every Morning

High-Carb Foods That Are Really Healthy

People are often surprised by how even innocent habits can be the cause of their declining health. Many times, we take on these habits, maybe due to stress or due to work. However, it is important to understand the implications of it and how to counter its effects. A common habit that we all have is scrolling on our phones or watching the television before we go to sleep. Many people find it comforting to relax their minds like this. However, it may be doing more harm to your health than good. A new study suggests that a common habit, being exposed to light at night, might be increasing your chances of developing heart disease, heart failure, and stroke. Researchers found that people who had more light exposure from things like TVs, phones, and laptops during nighttime hours faced a higher risk of these serious heart-related problems. Tracking Light Exposure and Heart Health The study looked at data from nearly 89,000 people in Britain. These participants wore special wrist sensors that measured how much light they were exposed to. Their health was then followed using their medical records for almost 10 years. The results showed that those who had the most light exposure at night had a significantly higher risk: 23-32% higher risk of developing coronary artery disease (a common type of heart disease).42-47% higher risk of having a heart attack.28-32% more likely to suffer from an irregular heartbeat.28-30% more likely to experience a stroke.Who Might Be Most Affected? The researchers also noticed some specific trends. The links between more nighttime light exposure and heart failure or coronary artery disease were stronger for women. Meanwhile, the connections with heart failure and irregular heartbeat were more pronounced in younger people. The researchers concluded that "Night light exposure was a significant risk factor for developing cardiovascular diseases." They believe that "avoiding light at night may be a useful strategy for reducing risks of cardiovascular diseases," in addition to existing preventative measures.It's well-known that light at night can disrupt your circadian rhythm, which is your body's natural internal clock controlling your sleep-wake cycle. Previous studies have shown that people whose body clocks are often disrupted, like shift workers, are more prone to heart problems. Interestingly, the research, which analyzed a massive 13 million hours of light exposure data, also found a positive side. People who were exposed to brighter light during the day had lower risks of coronary heart disease, heart failure, and stroke. New Factor in Heart Health Prevention Experts behind the study stated that this was the first time night light had been identified as an important risk factor by looking at individuals' actual light exposure patterns and their heart health. They highlighted that heart diseases are a leading cause of illness and death worldwide. Current advice for preventing these diseases includes eating healthy, getting enough physical activity, and avoiding alcohol and tobacco. This study adds a new recommendation: avoiding night light could be a promising way to further prevent cardiovascular diseases. 

common nighttime habit could lead you to cardiovascular health issues: study

Ishita Roy

Health News

A Ugandan Scientist's Photos Reveal How Marburg Virus Can Spread To Different Species

a ugandan scientist's photos reveal how marburg virus can spread to different species

Over 70 Million Indians Affected By Rare Diseases Amid Ongoing Challenges

over 70 million indians affected by rare diseases amid ongoing challenges

The Marburg Virus Is Back In Focus Thanks To A Ugandan Scientist, Here's What We Know So Far

the marburg virus is back in focus thanks to a ugandan scientist, here's what we know so far

WHO Releases First-Ever Clinical Guidelines For Arboviral Diseases Amid Rising Global Threat

who releases first-ever clinical guidelines for arboviral diseases amid rising global threat

Just one week before a landmark <span>HIV</span> vaccine trial was set to begin in South Africa, researchers received devastating news: the United States government was withdrawing its funding. The message—abrupt and brief—ordered a halt to all work.

The decision, made under the Trump administration, pulled $46 million in funding for a major research project called BRILLIANT, leaving scientists and healthcare professionals in one of the world’s hardest-hit regions scrambling to keep their work alive. South Africa carries one of the highest burdens of HIV globally, and the clinical trials were seen as a significant opportunity to turn the tide.

<h4>A Major Setback for Global HIV Efforts</h4>

The research project aimed to develop an HIV vaccine tailored to the region’s unique viral strains and genetic diversity, with hopes of benefiting populations worldwide. Instead, the project has ground to a halt.

According to Associated Press reporting, the funding cut was part of a larger move to reduce U.S. foreign aid, with former President Donald Trump shifting focus to domestic priorities. The Trump administration also cited unfounded claims about the persecution of South Africa's white Afrikaner minority, contributing to the decision to withdraw broader aid.

As a result, USAID and the President’s Emergency Plan for <span>AIDS</span> Relief (PEPFAR)—which had provided approximately $400 million annually to South Africa—have scaled back significantly. The consequences, experts warn, could be catastrophic not only for South Africa but for global HIV prevention.

<h4>Scientists Warn of Long-Term Damage</h4>

Dr. Glenda Gray, head of the BRILLIANT program, called the move a severe blow to scientific progress. “We do the trials better, faster and cheaper than anywhere else in the world,” she told AP. “Without South Africa as part of these programs, the world is much poorer.”

South African scientists have long played an essential role in global health research. During the COVID-19 pandemic, they were pivotal in testing vaccines like Johnson &amp; Johnson and Novavax, and their genomic surveillance identified a major variant of concern. They have also contributed to clinical trials for lenacapavir, the world’s only twice-a-year HIV prevention shot recently approved by the U.S. FDA.

At the University of the Witwatersrand, lab technician Nozipho Mlotshwa is one of many researchers whose future is uncertain. Her job, funded through a research grant, now hangs in the balance. “It’s very sad and devastating,” she said. “We’ll also miss out collaborating with other scientists across the continent.”

According to South Africa’s health department, at least 100 HIV researchers have already lost their jobs, and funding for postdoctoral students is at risk. Across the country, 8,000 health workers in the HIV program have been laid off. These include data collectors who monitored patient progress and HIV counselors who worked in remote areas.

Professor Abdullah Ely, who leads one of the vaccine development teams, said early trial data was promising, showing positive immune responses. But all progress has now stalled. “That momentum has all kind of had to come to a halt,” he said.

The South African government has warned that replacing the lost U.S. funding will be extremely difficult. An umbrella body for the country’s universities, Universities South Africa, has requested over $110 million from the national treasury to sustain vital health research—but even that may not be enough.

UNAIDS executive director Winnie Byanyima visited South Africa in June and voiced deep concern over the future of HIV care and research, not only in South Africa but across the continent. Countries like Nigeria, Zambia, Burundi, and Ivory Coast are now trying to increase their own HIV resources.

“But let’s be clear,” she said. “What they are putting down will not be funding in the same way that the American resources were funding.”

Without swift action to replace the lost support, millions of lives could be at risk. The United Nations has warned that if funding gaps aren’t filled, millions may die by 2029 from diseases that could have been prevented.

US halts HIV vaccine funding in south africa

health and wellness

US news

US halts funding in South Africa

HIV AIDS

AIDS

Just one week before a landmark HIV vaccine trial was set to begin in South Africa, researchers received devastating news: the United States government was withdrawing its funding. The message—abrupt and brief—ordered a halt to all work.The decision, made under the Trump administration, pulled $46 million in funding for a major research project called BRILLIANT, leaving scientists and healthcare professionals in one of the world’s hardest-hit regions scrambling to keep their work alive. South Africa carries one of the highest burdens of HIV globally, and the clinical trials were seen as a significant opportunity to turn the tide.A Major Setback for Global HIV EffortsThe research project aimed to develop an HIV vaccine tailored to the region’s unique viral strains and genetic diversity, with hopes of benefiting populations worldwide. Instead, the project has ground to a halt.According to Associated Press reporting, the funding cut was part of a larger move to reduce U.S. foreign aid, with former President Donald Trump shifting focus to domestic priorities. The Trump administration also cited unfounded claims about the persecution of South Africa's white Afrikaner minority, contributing to the decision to withdraw broader aid.As a result, USAID and the President’s Emergency Plan for AIDS Relief (PEPFAR)—which had provided approximately $400 million annually to South Africa—have scaled back significantly. The consequences, experts warn, could be catastrophic not only for South Africa but for global HIV prevention.Scientists Warn of Long-Term DamageDr. Glenda Gray, head of the BRILLIANT program, called the move a severe blow to scientific progress. “We do the trials better, faster and cheaper than anywhere else in the world,” she told AP. “Without South Africa as part of these programs, the world is much poorer.”South African scientists have long played an essential role in global health research. During the COVID-19 pandemic, they were pivotal in testing vaccines like Johnson & Johnson and Novavax, and their genomic surveillance identified a major variant of concern. They have also contributed to clinical trials for lenacapavir, the world’s only twice-a-year HIV prevention shot recently approved by the U.S. FDA.Jobs Lost, Lives DisruptedAt the University of the Witwatersrand, lab technician Nozipho Mlotshwa is one of many researchers whose future is uncertain. Her job, funded through a research grant, now hangs in the balance. “It’s very sad and devastating,” she said. “We’ll also miss out collaborating with other scientists across the continent.”According to South Africa’s health department, at least 100 HIV researchers have already lost their jobs, and funding for postdoctoral students is at risk. Across the country, 8,000 health workers in the HIV program have been laid off. These include data collectors who monitored patient progress and HIV counselors who worked in remote areas.Looming Health CrisisProfessor Abdullah Ely, who leads one of the vaccine development teams, said early trial data was promising, showing positive immune responses. But all progress has now stalled. “That momentum has all kind of had to come to a halt,” he said.The South African government has warned that replacing the lost U.S. funding will be extremely difficult. An umbrella body for the country’s universities, Universities South Africa, has requested over $110 million from the national treasury to sustain vital health research—but even that may not be enough.A Wider Regional ImpactUNAIDS executive director Winnie Byanyima visited South Africa in June and voiced deep concern over the future of HIV care and research, not only in South Africa but across the continent. Countries like Nigeria, Zambia, Burundi, and Ivory Coast are now trying to increase their own HIV resources.“But let’s be clear,” she said. “What they are putting down will not be funding in the same way that the American resources were funding.”Without swift action to replace the lost support, millions of lives could be at risk. The United Nations has warned that if funding gaps aren’t filled, millions may die by 2029 from diseases that could have been prevented.

hiv vaccine research in south africa crumbles as u.s. pulls funding

This Three-Step Test Could Spot Early Signs of Diabetes - Here's How It Is Conducted

This Three-Step Test Could Spot Early Signs of Diabetes

Nutrition

Your Favorite Junk Foods Could Be Stealing 36 Minutes Of Life Per Bite

your favorite junk foods could be stealing 36 minutes of life per bite

Is There Any Truth Behind The Saying, 'An Apple A Day Keeps Doctors Away'?

is there any truth behind the saying, 'an apple a day keeps doctors away'?

Increase Risk Of Aggressive Brain Cancer Linked To Common Sweetener Used All Over The World

increase risk of aggressive brain cancer linked to common sweetener used all over the world

<span>Diabetes</span> is a huge global problem, causing serious health issues like <span>blindness and heart attacks</span>. Numbers are soaring, with many untreated. According to the World Health Organization, cases soared from 200 million in 1990 to 830 million in 2022. It causes serious issues like blindness and heart attacks. Many go untreated and the best approach is preventing it by knowing your risk. 

<span>Diabetes UK</span> offers a simple online test to help you understand your risk of developing type 2 diabetes over the next ten years. This tool not only gives you an idea of your risk but also provides advice on what steps to take next, from continuing your healthy habits to contacting your doctor for more checks. 

<h2>Understanding Your Risk: Why It Matters </h2>

The charity warns that you can have type 2 diabetes for years without even knowing it. More than 3.2 million people in the UK are currently at risk due to their blood sugar levels. To take the test, you need to be over 18 and not pregnant. The test requires some basic information like your waist size, height, and weight to be accurate. This quick, seven-question survey also considers your age, ethnic background, and family health history. 

The online test places people into one of four risk groups: low, medium, high, or very high. Here's what those categories mean for your chances of being diagnosed with type 2 diabetes in the next decade: 

<strong>Very High Risk:</strong> You have a 1 in 4 (25%) chance.

<strong>High Risk:</strong> You have a 1 in 10 (10%) chance.

<strong>Medium Risk: </strong>You have a 1 in 35 (2.8%) chance.

<strong>Low Risk:</strong> You have a 1 in 100 (1%) chance. 

If you're in the 'very high risk' category, the test will suggest you get a blood test from your GP and ask about support to lower your risk. Diabetes UK can also email your results and advice, including a letter you can show your doctor. 

<h2>Factors Influencing Your Risk Score </h2>

The test considers things you can't control, like your ethnicity, age, and height. However, it also highlights the importance of your waist size and BMI (<span>Body Mass Index</span>) in lowering your risk. For instance:

<ul><li>A waist size over 110cm automatically adds nine points to your score, putting you in the medium risk category even before other factors are considered.</li><li>A waist size under 90cm adds no points.</li><li>Similarly, a BMI of 35 or higher adds eight points, enough to place you in the medium risk category.</li><li>A BMI below 25 adds no points.</li></ul>

Unlike type 1 diabetes, type 2 diabetes is often preventable. Studies have shown that making changes to your lifestyle can actually halve your risk. Effective ways to prevent it include eating a balanced diet, exercising regularly, and managing your weight if needed. 

Experts advise, "It's important to keep checking your risk regularly, especially if anything changes, like if you've put on weight or feel unwell." It's also important to be aware of the <span>symptoms of diabetes</span>, especially if you have a higher risk due to your age, ethnic background, or family history. These symptoms include: 

<ul><li>Urinating more often than usual</li><li>Feeling very thirsty</li><li>Feeling unusually tired</li><li>Losing weight without trying</li><li>Genital thrush (a yeast infection)</li><li>Cuts and wounds that heal slowly</li><li>Blurred vision</li><li>Feeling more hungry than usual</li></ul>

Diabetes

Early Signs of Diabetes

blindness and heart attacks

Diabetes UK

Body Mass Index

symptoms of diabetes

Diabetes is a huge global problem, causing serious health issues like blindness and heart attacks. Numbers are soaring, with many untreated. According to the World Health Organization, cases soared from 200 million in 1990 to 830 million in 2022. It causes serious issues like blindness and heart attacks. Many go untreated and the best approach is preventing it by knowing your risk. Diabetes UK offers a simple online test to help you understand your risk of developing type 2 diabetes over the next ten years. This tool not only gives you an idea of your risk but also provides advice on what steps to take next, from continuing your healthy habits to contacting your doctor for more checks. Understanding Your Risk: Why It Matters The charity warns that you can have type 2 diabetes for years without even knowing it. More than 3.2 million people in the UK are currently at risk due to their blood sugar levels. To take the test, you need to be over 18 and not pregnant. The test requires some basic information like your waist size, height, and weight to be accurate. This quick, seven-question survey also considers your age, ethnic background, and family health history. What Your Risk Category Means The online test places people into one of four risk groups: low, medium, high, or very high. Here's what those categories mean for your chances of being diagnosed with type 2 diabetes in the next decade: Very High Risk: You have a 1 in 4 (25%) chance.High Risk: You have a 1 in 10 (10%) chance.Medium Risk: You have a 1 in 35 (2.8%) chance.Low Risk: You have a 1 in 100 (1%) chance. If you're in the 'very high risk' category, the test will suggest you get a blood test from your GP and ask about support to lower your risk. Diabetes UK can also email your results and advice, including a letter you can show your doctor. Factors Influencing Your Risk Score The test considers things you can't control, like your ethnicity, age, and height. However, it also highlights the importance of your waist size and BMI (Body Mass Index) in lowering your risk. For instance:A waist size over 110cm automatically adds nine points to your score, putting you in the medium risk category even before other factors are considered.A waist size under 90cm adds no points.Similarly, a BMI of 35 or higher adds eight points, enough to place you in the medium risk category.A BMI below 25 adds no points.Preventing Type 2 Diabetes Unlike type 1 diabetes, type 2 diabetes is often preventable. Studies have shown that making changes to your lifestyle can actually halve your risk. Effective ways to prevent it include eating a balanced diet, exercising regularly, and managing your weight if needed. Experts advise, "It's important to keep checking your risk regularly, especially if anything changes, like if you've put on weight or feel unwell." It's also important to be aware of the symptoms of diabetes, especially if you have a higher risk due to your age, ethnic background, or family history. These symptoms include: Urinating more often than usualFeeling very thirstyFeeling unusually tiredLosing weight without tryingGenital thrush (a yeast infection)Cuts and wounds that heal slowlyBlurred visionFeeling more hungry than usual

this three-step test could spot early signs of diabetes - here's how it is conducted

It Took 26 Doctors, 37 Procedures, and 17 Years For New York-Based Journalist To Get Her Diagnosis Right

it took 26 doctors, 37 procedures, and 17 years for new york-based journalist to get her diagnosis right

UKHSA Issues A Health Directive For People Travelling Abroad - Essential Travel Checklist

ukhsa issues a health directive for people travelling abroad - essential travel checklist

Child Dies Of Measles In UK Hospital As Health Officials Warn Of Rapid Community Spread

child dies of measles in uk hospital as health officials warn of rapid community spread

In a landmark move to strengthen global preparedness and response to mosquito-borne illnesses, the World Health Organization (WHO) has released its first-ever integrated clinical guidelines for the management of <span>arboviral diseases</span>. These include some of the most common and dangerous viruses transmitted by mosquitoes — <span>dengue</span>, chikungunya, Zika, and yellow fever.

The guidelines, published earlier this month, aim to provide frontline healthcare workers, hospitals, and policymakers with evidence-based, standardized protocols to treat both mild and severe cases. With arboviral diseases rapidly expanding in reach and impact, particularly in tropical and subtropical regions, WHO hopes these clinical tools will help reduce mortality and morbidity rates.

Arboviral diseases are viral infections transmitted by arthropods, mainly mosquitoes — especially the Aedes aegypti species. This single vector can carry and transmit multiple viruses at once, which makes controlling outbreaks even more challenging.

According to WHO, over 5.6 billion people — more than half of the global population — are at risk of contracting arboviral infections. These diseases often start with non-specific, flu-like symptoms such as fever, rash, and joint pain, making accurate diagnosis difficult without laboratory confirmation. However, they can lead to severe complications, including hemorrhage, neurological damage, or organ failure, if left untreated or mismanaged.

<h4>Why the Guidelines Are Critical Now</h4>

In a statement, WHO underscored the urgency of a unified global response, citing increasing frequency and severity of arbovirus outbreaks, driven by climate change, urbanization, global travel, and weakened public health systems.

“Outbreaks of arboviral diseases are becoming more frequent, widespread, and severe,” said the WHO. “The new clinical guidelines aim to help health workers distinguish between these infections, which often have overlapping symptoms, and manage cases more effectively even when diagnostic tools are scarce.”

In many endemic regions, multiple arboviruses circulate simultaneously, further complicating diagnosis and treatment. This is where the integrated approach — which applies common principles of care across different arboviral diseases — can help streamline responses during outbreaks.

The new <span>WHO guidelines</span> cover clinical care protocols for both non-severe and severe forms of dengue, chikungunya, Zika, and yellow fever. The recommendations are tailored to help practitioners manage symptoms, avoid harmful treatments, and recognize complications early.

<ul><li>Use oral fluids to prevent dehydration.</li><li>Treat pain and fever with paracetamol or metamizole.</li><li>Avoid NSAIDs (non-steroidal anti-inflammatory drugs) like ibuprofen.</li><li>Avoid corticosteroids unless symptoms worsen.</li></ul>

<strong>For Severe Hospitalized Cases:</strong>

<ul><li>Use crystalloid fluids (not colloids) for IV hydration.</li><li>Monitor capillary refill time and lactate levels to guide fluid resuscitation.</li><li>Apply passive leg raise test to assess shock and fluid responsiveness.</li><li>Avoid corticosteroids and immunoglobulin therapies.</li><li>Do not transfuse platelets unless there is active bleeding, even in patients with low platelet counts.</li><li>In yellow fever-related liver failure, administer intravenous N-acetylcysteine.</li><li>Use experimental drugs like TY014 (monoclonal antibodies) and sofosbuvir for yellow fever only in research settings.</li></ul>

<h4>A Step Toward Global Health Security</h4>

These new protocols are built on the latest clinical and scientific evidence, and WHO confirmed that they will be updated as new research becomes available. By standardizing treatment across countries, the guidelines are expected to improve patient outcomes and prepare health systems to tackle emerging threats.

As arboviral infections continue to grow in complexity and reach, experts say that timely, consistent, and data-driven care can mean the difference between recovery and tragedy — especially in resource-limited settings.

WHO’s unified approach offers a roadmap for healthcare workers worldwide to navigate the rising tide of mosquito-borne illnesses — and better protect the billions at risk.

arboviral diseases

WHO guidelines

mosquito borne diseases

dengue

zika virus

malaria

In a landmark move to strengthen global preparedness and response to mosquito-borne illnesses, the World Health Organization (WHO) has released its first-ever integrated clinical guidelines for the management of arboviral diseases. These include some of the most common and dangerous viruses transmitted by mosquitoes — dengue, chikungunya, Zika, and yellow fever.The guidelines, published earlier this month, aim to provide frontline healthcare workers, hospitals, and policymakers with evidence-based, standardized protocols to treat both mild and severe cases. With arboviral diseases rapidly expanding in reach and impact, particularly in tropical and subtropical regions, WHO hopes these clinical tools will help reduce mortality and morbidity rates.What Are Arboviral Diseases?Arboviral diseases are viral infections transmitted by arthropods, mainly mosquitoes — especially the Aedes aegypti species. This single vector can carry and transmit multiple viruses at once, which makes controlling outbreaks even more challenging.According to WHO, over 5.6 billion people — more than half of the global population — are at risk of contracting arboviral infections. These diseases often start with non-specific, flu-like symptoms such as fever, rash, and joint pain, making accurate diagnosis difficult without laboratory confirmation. However, they can lead to severe complications, including hemorrhage, neurological damage, or organ failure, if left untreated or mismanaged.Why the Guidelines Are Critical NowIn a statement, WHO underscored the urgency of a unified global response, citing increasing frequency and severity of arbovirus outbreaks, driven by climate change, urbanization, global travel, and weakened public health systems.“Outbreaks of arboviral diseases are becoming more frequent, widespread, and severe,” said the WHO. “The new clinical guidelines aim to help health workers distinguish between these infections, which often have overlapping symptoms, and manage cases more effectively even when diagnostic tools are scarce.”In many endemic regions, multiple arboviruses circulate simultaneously, further complicating diagnosis and treatment. This is where the integrated approach — which applies common principles of care across different arboviral diseases — can help streamline responses during outbreaks.Key Recommendations from WHOThe new WHO guidelines cover clinical care protocols for both non-severe and severe forms of dengue, chikungunya, Zika, and yellow fever. The recommendations are tailored to help practitioners manage symptoms, avoid harmful treatments, and recognize complications early.For Non-Severe Cases:Use oral fluids to prevent dehydration.Treat pain and fever with paracetamol or metamizole.Avoid NSAIDs (non-steroidal anti-inflammatory drugs) like ibuprofen.Avoid corticosteroids unless symptoms worsen.For Severe Hospitalized Cases:Use crystalloid fluids (not colloids) for IV hydration.Monitor capillary refill time and lactate levels to guide fluid resuscitation.Apply passive leg raise test to assess shock and fluid responsiveness.Avoid corticosteroids and immunoglobulin therapies.Do not transfuse platelets unless there is active bleeding, even in patients with low platelet counts.In yellow fever-related liver failure, administer intravenous N-acetylcysteine.Use experimental drugs like TY014 (monoclonal antibodies) and sofosbuvir for yellow fever only in research settings.A Step Toward Global Health SecurityThese new protocols are built on the latest clinical and scientific evidence, and WHO confirmed that they will be updated as new research becomes available. By standardizing treatment across countries, the guidelines are expected to improve patient outcomes and prepare health systems to tackle emerging threats.As arboviral infections continue to grow in complexity and reach, experts say that timely, consistent, and data-driven care can mean the difference between recovery and tragedy — especially in resource-limited settings.WHO’s unified approach offers a roadmap for healthcare workers worldwide to navigate the rising tide of mosquito-borne illnesses — and better protect the billions at risk.

About Us

Contact Us

Terms & Conditions

Privacy Policy

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.

Common Nighttime Habit Could Lead You To Cardiovascular Health Issues: Study

Quick Stories

HIV Vaccine Research In South Africa Crumbles As U.S. Pulls Funding

This Three-Step Test Could Spot Early Signs of Diabetes - Here's How It Is Conducted

WHO Releases First-Ever Clinical Guidelines For Arboviral Diseases Amid Rising Global Threat

Health Conditions A-Z

Damar Hamlin Is Back For 2025 NFL Season, But His Cardiac Arrest Has Changed The Course Of The Game

'Jaws' Star Richard Dreyfuss Skips Fan Event After Being Diagnosed With Severe Bronchitis, Know What It Is

HIV Vaccine Research In South Africa Crumbles As U.S. Pulls Funding